Asia Pacific Chondroitin Sulfate Market Size & Outlook
Asia Pacific chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
Asia Pacific chondroitin sulfate market highlights
- The Asia Pacific chondroitin sulfate market generated a revenue of USD 313.5 million in 2022.
- The market is expected to grow at a CAGR of 4% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 313.5 million |
| Market revenue in 2030 | USD 427.5 million |
| Growth rate | 4% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 25.6% of the global chondroitin sulfate market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 427.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 38.02% in 2022. Horizon Databook has segmented the Asia Pacific chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
In 2020, Asia Pacific was the second largest regional market for chondroitin sulfate, which can be attributed to the expansion of end-use industries including nutraceutical, pharmaceutical, personal care, and cosmetics. Increasing production of chondroitin sulfate in the region and increasing exports from key countries such as China and Japan are anticipated to contribute to the market growth.
Chondroitin sulfate is primarily used in the treatment of osteoarthritis, in eye drops, for heart diseases & high cholesterol, and to reduce pain in the joints. Burgeoning population in developing economies such as China and India along with growing aging population has resulted in a high prevalence of osteoarthritis as well as several issues related to joint health.
Increased prevalence of osteoarthritis coupled with rising consumption of chondroitin sulfate for the treatment of several medical conditions is anticipated to drive the product demand in pharmaceutical sector in the region.
Reasons to subscribe to Asia Pacific chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific chondroitin sulfate market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific chondroitin sulfate market size, by country, 2017-2030 (US$M)
Asia Pacific Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
